Therapeutic drug monitoring of Tacrolimus in kidney transplantation: 9- month follow-up

Transplantation Proceedings

Volumn 30, Issue 8, 1998, Pages 4068-4069

  Brunet, Mercè ^a,b   Torregrosa, J V ^a   Oppenheimer, F ^a   Corbella, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TACROLIMUS;

ADULT; AGED; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AGED; CREATININE; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TACROLIMUS; TIME FACTORS;

EID: 0032411887     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01343-8     Document Type: Conference Paper

References (3)

1. 1. Vicenti F, Laskow DA, Neylan JF, et al: Transplantation 61:1576, 1996
2. 2. Pou L, Brunet M, Bilbao I, et al: Therapeutic Drug Monitoring (in press)
3. 3. Brunet M, Pou L, Manzanares C, et al: Therapeutic Drug Monitoring (in press)